News
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
14don MSN
The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.
The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...
A CDC advisory panel voted 5–1 to recommend only flu vaccines without the preservative thimerosal, a mercury-containing ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
10h
Stocktwits on MSNGSK Stock Gains As Flu Vaccine Rollout Begins And US Recovers From Most Severe Season In 15 YearsShares of GSK rose on Thursday after the company announced it had begun shipping its seasonal flu vaccines, Fluarix and ...
The Advisory Committee on Immunization Practices (ACIP), recently remade by Health and Human Services Secretary Robert F.
The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...
In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results